Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes
2004 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
2020 StandoutScience
The Regulation of Type I Interferon Production by Paramyxoviruses
2009
The effect of COVID certificates on vaccine uptake, health outcomes, and the economy
2022 StandoutNobel
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings
2014
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea
2015
Virological assessment of hospitalized patients with COVID-2019
2020 StandoutNature
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
2012
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
A new coronavirus associated with human respiratory disease in China
2020 StandoutNature
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
2015
Generation of mouse-induced pluripotent stem cells with plasmid vectors
2010 StandoutNobel
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
2015
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
2014
Clinical and immunological features of severe and moderate coronavirus disease 2019
2020 Standout
MERS-CoV spike protein: Targets for vaccines and therapeutics
2016
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 Standout
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
2005 StandoutNature
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
The V Proteins of Simian Virus 5 and Other Paramyxoviruses Inhibit Induction of Interferon-β
2002
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
2013 Nature
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Treating hepatitis C
2005 StandoutNobel
Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
2014
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
2013
The Hepatitis C Virus Nonstructural Protein 4B Is an Integral Endoplasmic Reticulum Membrane Protein
2001 StandoutNobel
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
2013
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The effect of large-scale anti-contagion policies on the COVID-19 pandemic
2020 StandoutNature
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
2020 Standout
Evidence for Camel-to-Human Transmission of MERS Coronavirus
2014
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein
2003
Replication of hepatitis C virus
2007 StandoutNobel
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
A cis -Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication
2004 StandoutNobel
Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012
2013
The ‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring ‘2A-like’ sequences
2001
Subcellular Localization, Stability, and trans -Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines
2000 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
The NS5A Protein of Bovine Viral Diarrhea Virus Contains an Essential Zinc-Binding Site Similar to That of the Hepatitis C Virus NS5A Protein
2006 StandoutNobel
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
2012
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
2013
Simian Virus 5 V Protein Acts as an Adaptor, Linking DDB1 to STAT2, To Facilitate the Ubiquitination of STAT1
2005
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
2020 Standout
Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells
2003 StandoutNobel
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins
1998 StandoutNobel
MERS-CoV spike protein: a key target for antivirals
2016
TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium
2013
A Dynamic View of Hepatitis C Virus Replication Complexes
2008 StandoutNobel
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
2015
Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System
2001 StandoutNobel
Works of A Bermingham being referenced
Estimating influenza vaccine effectiveness using routinely collected laboratory data
2009
NP:P and NP:V Interactions of the Paramyxovirus Simian Virus 5 Examined Using a Novel Protein:Protein Capture Assay
1996
A human metapneumovirus outbreak at a community hospital in England, July to September 2010
2012
Inducible expression of the P, V, and NP genes of the paramyxovirus simian virus 5 in cell lines and an examination of NP-P and NP-V interactions
1995
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012
2012